Core Viewpoint - BGM Group is set to release its unaudited financial results for the first half of 2025 on July 24, 2025, before U.S. financial markets open [1] Company Overview - BGM Group Ltd. focuses on technology sectors including AI applications, intelligent robots, algorithmic computing power, cloud computing, and biopharmaceuticals [2] AI Application Implementation - The company utilizes advanced analytics and AI Agent technology through its platforms Du Xiao Bao and Bao Wang to deliver AI solutions and intelligent robot services to insurance companies, brokers, and consumers [3] - Services encompass sales and marketing, underwriting assessment, claims processing, and customer service, with capabilities in consumer data analysis and customized service provision [3] Biopharmaceuticals Division - BGM's biopharmaceutical division produces oxytetracycline API, crude heparin sodium, and licorice preparations, serving global markets in animal husbandry, pharmaceuticals, and drug retail [4] - The integration of AI-assisted decision-making enhances production efficiency, supply chain optimization, and market trend prediction, providing a scientific basis for management decisions and high-quality products for consumers [4]

Company Overview - BGM Group Ltd. is a leading AI technology company focused on AI applications, intelligent robots, algorithmic computing power, cloud computing, and biopharmaceuticals [5] - The company utilizes advanced analytics and AI agent technology to provide comprehensive AI solutions and intelligent robot services, particularly in the insurance sector [6] Acquisition Details - BGM Group has entered into a definitive agreement to acquire HM Management Company Limited for approximately RMB300 million (US$41.7 million) in an all-stock transaction [1][2] - The acquisition involves issuing 16,663,427 Class A ordinary shares at $2.50 per share to gain 100% ownership of HM Management and its subsidiaries [2] Strategic Impact - The acquisition of Shuda Technology and New Media Star enhances BGM's AI application portfolio and integrates existing resources from its AI insurance and mobility businesses [4] - Shuda Technology specializes in AI-driven enterprise efficiency solutions, while New Media Star operates a growing AI tools platform [3] - The addition of these companies is expected to foster technological creativity and drive industry-wide impact, positioning BGM for rapid expansion into market opportunities [4] Industry Positioning - BGM aims to create a leading ecosystem of AI agent applications, leveraging over 100 industry-specific AI modules and an established developer ecosystem [4] - The company’s biopharmaceutical division integrates AI-assisted decision-making to optimize supply chains and improve process efficiency [7]

Group 1 - BGM Group Ltd. has completed the acquisition of YX Management Company Ltd., enhancing its capabilities in intelligent mobility technology, with a valuation of US$95.0 million [1][2] - Following the acquisition, YX's shareholders own approximately 32.6% of BGM's equity interests and about 2.2% of the total voting power [1] - The acquisition is a significant step in BGM's AI-driven transformation, aimed at integrating AI into its core businesses, including intelligent insurance and digital services [2][3] Group 2 - The CEO of BGM stated that the integration of YX's expertise will accelerate the application of AI across key sectors, advancing towards an AI Agent-driven model [3] - BGM focuses on technology fields such as AI application, intelligent robots, algorithmic computing power, cloud computing, and biopharmaceuticals [4] - The group utilizes advanced analytics and AI Agent technology to provide comprehensive AI solutions for insurance companies, covering various key scenarios [5] Group 3 - In the biopharmaceutical sector, BGM's division produces oxytetracycline API, crude heparin sodium, and licorice preparations, integrating AI-assisted decision-making for supply chain optimization [6]

CHENGDU, China, April 21, 2025 /PRNewswire/ -- BGM Group Ltd. (Nasdaq: BGM) today announced that it has signed a definitive transaction agreement with the existing shareholders of Wonder Dragon Global Limited ("Wonder Dragon"), to acquire 100% of the equity interests of Wonder Dragon by issuing 38,165,290 Class A ordinary shares at a price of $2 per share, for a total transaction valuation of RMB550 million. The transaction is expected to be completed in the second quarter of 2025. Wonder Dragon possesses o ...

Core Viewpoint - BGM Group Ltd. has signed a definitive agreement to acquire 100% of YX Management Company Ltd. for US$95 million, which will enhance BGM's AI-driven platform, DuXiaoBao, and is expected to be completed by June 2025 [1][3]. Group 1: Acquisition Details - BGM will issue 47.5 million class A ordinary shares to acquire YX, valuing the company at US$95 million [1]. - Following the acquisition, YX's shareholders will hold approximately 32.8% of BGM's total outstanding shares and about 2.2% of its voting power [1]. Group 2: YX Team Expertise - The YX team consists of executives and technology experts from major Chinese internet companies like Alibaba and Didi, with experience in large-scale platform development [2]. - Core members have been involved in significant projects such as Taobao Mobile and Didi's ride-hailing services, showcasing their capabilities in digital transformation and AI commercialization [2]. Group 3: Strategic Impact - The integration of the YX team is expected to create a "multiplier effect" through industry breakthroughs and ecosystem synergy, enhancing BGM's leadership in intelligent technology innovation [3]. - The operational experience and strategies of the YX team will position AI as a key driver for BGM's value growth and sustainable returns [3]. Group 4: Company Focus Areas - BGM Group Ltd. focuses on AI applications, intelligent robots, algorithmic computing, cloud computing, and biopharmaceuticals [4]. - The company utilizes big data and AI technologies to provide solutions for insurance companies, covering various scenarios like sales, underwriting, and customer service [5]. - In biopharmaceuticals, BGM produces key products for global markets, integrating AI for supply chain optimization and process efficiency [6].

Core Viewpoint - BGM Group Ltd is undergoing a significant leadership transition aimed at enhancing its technological transformation and sustainable growth, with a focus on innovation and strategic upgrades in response to market opportunities and challenges [1][5]. Leadership Changes - Mr. Zhanchang Xin has resigned as Chairman, effective March 1, 2025, and will be succeeded by Mr. Chen Xin, the current CEO [2][3]. - Mr. Chen Xin has extensive experience in market consolidation and corporate management, having led the acquisition of Duxiaobao Intelligent Technology and previously worked in autonomous driving algorithm development [3][4]. - Mr. Lin Zhang has been appointed as an independent director and will chair the compensation committee, bringing rich experience in AI model architecture and deep learning projects [4][5]. Strategic Focus - The company is strategically focused on technology fields including AI applications, intelligent robots, algorithmic computing power, cloud computing, and biopharmaceuticals [6]. - BGM Group utilizes big data mining and AI Agent technology to provide comprehensive AI solutions and intelligent robot services, particularly in the insurance sector [7]. - In biopharmaceuticals, the company produces key products like oxytetracycline API and crude heparin sodium, integrating AI-assisted decision-making to optimize production and supply chain processes [8].